Q
Qianwen Zhao
Researcher at Sichuan University
Publications - 6
Citations - 927
Qianwen Zhao is an academic researcher from Sichuan University. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 576 citations.
Papers
More filters
Journal ArticleDOI
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.
Qianwen Zhao,Meng Meng,Rajesh Kumar,Yinlian Wu,Jiaofeng Huang,Ningfang Lian,Yunlei Deng,Su Lin +7 more
TL;DR: The point prevalence of severe COVID‐19 in patients with pre‐existing COPD and those with ongoing smoking was evaluated and there was no publication bias as examined by the funnel plot and Egger's test.
Journal ArticleDOI
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.
Qianwen Zhao,Meng Meng,Rajesh Kumar,Yinlian Wu,Jiaofeng Huang,Yunlei Deng,Zhiyuan Weng,Li Yang +7 more
TL;DR: Lymphopenia is a prominent part of severe COVID-19 and a lymphocyte count of less than 1.5×109/L may be useful in predicting the severity clinical outcomes.
Journal ArticleDOI
Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis.
TL;DR: Patients with CHD, hypertension and diabetes are at greater risk for developing severe COVID-19 than those without these conditions, according to a systematic literature search and meta-analysis.
Journal ArticleDOI
Effect of a Functional Phospholipid Metabolome-Protein Association Pathway on the Mechanism of COVID-19 Disease Progression
Mingshan Xue,Teng Zhang,Zhangkai J. Cheng,B. Guo,Yifeng Zeng,Runpei Lin,Peiyan Zheng,Mingtao Liu,Fengyu Hu,Feng Li,Wensheng Zhang,Lu Li,Qianwen Zhao,Bao-Hong Sun,Xiaoping Tang +14 more
TL;DR: The role of Cer in maintaining the inflammatory internal environment, the modulation of procoagulant LPA by upstream fibrinolytic metabolites, and the role of PI and PC in predicting disease aggravation are discovered.
Journal ArticleDOI
Letter: metabolic dysfunction‐associated fatty liver disease increases risk of all‐cause mortality in patients with chronic hepatitis C
Qianwen Zhao,Yunlei Deng +1 more
TL;DR: In this article , Attia et al. compared the prevalence and characteristics of metabolic profiles among metabolicassociated fatty liver disease (MAFLD) patients with chronic hepatitis C virus (HCV) infection.